LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A Operating Income

The latest operating income for LFMDP is $-17M as of June 2026. That compares with $5.5M in the prior-year period — down 403.7% year over year. Investors often review this figure alongside LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A's historical trend and sector peers before judging valuation or financial health.

Over the past year, LFMDP's operating income moved from $5.5M to $-17M — a 403.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A's operating scale or balance-sheet position.

A operating income figure of $-17M for LFMDP is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting LFMDP's operating income ($-17M), review year-over-year change from $5.5M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A's operating income against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.